Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis

B. Paiva, M. V. Mateos, L. I. Sanchez-Abarca, N. Puig, M.-B. Vidriales, L. Lopez-Corral, L. A. Corchete, M. T. Hernandez, J. Bargay, F. de Arriba, J. de la Rubia, A.-I. Teruel, P. Giraldo, L. Rosinol, F. Prosper, A. Oriol, J. Hernandez, G. Esteves, J. J. Lahuerta, J. Blade, J. A. Perez-Simon, J. F. San Miguel
  • Blood, December 2015, American Society of Hematology
  • DOI: 10.1182/blood-2015-10-662320
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Dr Albert Oriol